XeroThera

Breakthrough tissue-engineering and nanoporous oxide-based platforms for controlled, targeted delivery of drugs and biological molecules. Product pipeline for clinicians and surgeons addressing prevention and treatment of surgical and bone infections (including MRSA), tissue-engineering scaffolds, surgical pain management, and diabetic wound therapy.
Load...
Load...
Load...
Load...
Load...
Employees
loading...
Funding Status
loading...
Established
loading...
Total Funding
loading...
ARR
loading...

Insights

Loading Insights...
Q1/2040}
Loading Insight content to display...
Loading Insights...
Q1/2040}
Loading Insight content to display...
Founders
loading...
Notable Customers
loading...

Funding

Workforce

Functional Distribution
N/A
Open Positions
N/A
Diversity
N/A
Loading